Secondary osteoporosis accounts for roughly 30% of osteoporosis cases in postmenopausal women and up to 50–80% of cases in men — yet it’s frequently missed because clinicians stop looking once they see a low bone density scan. Unlike primary (age-related) osteoporosis, secondary osteoporosis is caused by an identifiable medical condition, medication, or lifestyle factor that actively destroys bone. Finding and treating that root cause is the single most important step in management, and it’s what separates good outcomes from preventable fractures.
If you’ve been diagnosed with osteoporosis before age 50, have fractures that seem out of proportion to your bone density, or are losing bone despite standard treatment, secondary osteoporosis should be at the top of the differential. This guide covers the full spectrum of secondary osteoporosis causes, the diagnostic workup every patient deserves, and evidence-based management strategies that actually change outcomes.
What Makes Osteoporosis “Secondary”?
Primary osteoporosis is driven by aging and estrogen loss after menopause. Secondary osteoporosis means something else — a disease, a drug, a deficiency — is accelerating bone loss beyond what age alone would explain. The bone itself looks the same on DXA, but the treatment approach is fundamentally different because you have a treatable upstream cause.
The clinical clue is context. A 45-year-old man with a vertebral compression fracture, a 60-year-old woman on prednisone who fractures her hip, a 35-year-old with celiac disease and a T-score of -3.0 — these patients don’t just need bisphosphonates. They need a cause identified and addressed.
The 12+ Major Causes of Secondary Osteoporosis
The causes fall into three categories: medications, medical conditions, and lifestyle/nutritional factors. Here’s a practical breakdown:
| Category | Specific Cause | Mechanism of Bone Loss |
|---|---|---|
| Medications | Glucocorticoids (≥5 mg prednisone daily for ≥3 months) | Suppresses osteoblasts, increases osteoclast lifespan, reduces calcium absorption |
| Aromatase inhibitors (letrozole, anastrozole) | Profound estrogen suppression | |
| Anticonvulsants (phenytoin, carbamazepine) | Accelerates vitamin D metabolism via CYP450 induction | |
| GnRH agonists / androgen deprivation therapy | Hypogonadism-driven bone resorption | |
| Medical Conditions | Hyperthyroidism | Excess thyroid hormone increases bone turnover |
| Cushing’s syndrome / hypercortisolism | Same mechanism as exogenous glucocorticoids | |
| Hyperparathyroidism (primary) | Elevated PTH drives cortical bone resorption | |
| Celiac disease / malabsorption syndromes | Impaired calcium and vitamin D absorption | |
| Rheumatoid arthritis | Chronic inflammation (IL-6, TNF-α) + frequent steroid use | |
| Lifestyle/Other | Chronic alcohol use (≥3 drinks/day) | Direct osteoblast toxicity, nutritional deficiencies |
| Smoking | Reduces estrogen levels, impairs calcium absorption | |
| Anorexia nervosa / severe caloric restriction | Hypogonadism, low IGF-1, nutritional deficiency |
Glucocorticoid-induced osteoporosis (GIOP) deserves special emphasis because it’s the most common form of secondary osteoporosis — and bone loss begins within the first 3–6 months of steroid use, with fracture risk increasing before DXA scores even change significantly.
Diagnostic Workup: What Labs to Order
A DXA scan confirms low bone density (T-score ≤ -2.5 for osteoporosis, -1.0 to -2.5 for osteopenia), but it doesn’t tell you why. The real diagnostic value lies in the laboratory workup. Every patient with newly diagnosed osteoporosis — especially those under 50 or with unexpected fractures — should get a secondary causes panel.
Recommended Initial Lab Panel
- Complete metabolic panel (CMP) — screens for renal disease, hypercalcemia
- 25-hydroxyvitamin D — deficiency (<20 ng/mL) is present in up to 50% of osteoporosis patients
- Intact PTH — elevated in primary hyperparathyroidism and vitamin D deficiency
- TSH — suppressed TSH suggests hyperthyroidism or over-replacement of levothyroxine
- CBC — screens for multiple myeloma, other marrow pathology
- Serum protein electrophoresis (SPEP) — rules out myeloma in patients over 50 with unexplained osteoporosis
- 24-hour urine calcium — identifies hypercalciuria or malabsorption
- Testosterone (in men) — hypogonadism is the leading cause of male osteoporosis
- Celiac panel (tTG-IgA) — celiac disease is underdiagnosed and highly treatable
If the initial workup is unrevealing, consider checking 24-hour urinary free cortisol (Cushing’s), bone turnover markers (CTX, P1NP), and in selected cases, a bone marrow biopsy.
Management Strategies That Actually Work
Step 1: Treat the Underlying Cause
This is non-negotiable and the single biggest differentiator from primary osteoporosis management. Parathyroidectomy for hyperparathyroidism, a gluten-free diet for celiac disease, thyroid dose adjustment for iatrogenic hyperthyroidism — each of these can halt or partially reverse bone loss without any osteoporosis-specific medication.
For glucocorticoid-induced osteoporosis, the goal is always to use the lowest effective steroid dose for the shortest duration. When steroids can’t be stopped, pharmacologic bone protection should start early.
Step 2: Optimize the Bone-Building Basics
- Calcium: 1,000–1,200 mg daily (diet preferred over supplements)
- Vitamin D: Target 25(OH)D level of 30–50 ng/mL; most patients need 1,000–2,000 IU daily, some need more
- Weight-bearing exercise: 30 minutes most days — walking, resistance training, balance work
- Fall prevention: Home safety assessment, vision correction, medication review for sedating drugs
Step 3: Pharmacologic Therapy When Indicated
Bisphosphonates (alendronate, risedronate, zoledronic acid) remain the most widely used first-line agents. For glucocorticoid-induced osteoporosis specifically, the ACR recommends starting treatment if prednisone dose is ≥2.5 mg/day for ≥3 months in adults at moderate-to-high fracture risk.
Denosumab (Prolia) is an alternative for patients who can’t tolerate bisphosphonates or have renal impairment (eGFR <35 mL/min, where bisphosphonates are contraindicated).
Anabolic agents — teriparatide (Forteo) and romosozumab (Evenity) — are reserved for severe osteoporosis or patients who fracture on antiresorptive therapy. Teriparatide is particularly effective in glucocorticoid-induced osteoporosis, where it outperforms alendronate in head-to-head trials for increasing spine BMD and reducing vertebral fractures.
When to See a Doctor
You should push for a secondary osteoporosis workup if any of the following apply:
- You’re diagnosed with osteoporosis before age 50
- You’re a man with osteoporosis at any age
- You’ve had a fragility fracture (a fracture from a fall at standing height or less)
- You’re on chronic glucocorticoids, anticonvulsants, or aromatase inhibitors
- Your bone density is declining despite treatment
- You have a known condition linked to bone loss (RA, thyroid disease, celiac, etc.)
Don’t accept “it’s just aging” as an explanation without appropriate lab work. A secondary cause is found in up to 40% of postmenopausal women and the majority of men who are formally evaluated.
Frequently Asked Questions
Can secondary osteoporosis be reversed?
In many cases, yes — partially or fully. If the underlying cause is treatable (hyperparathyroidism removed surgically, celiac disease managed with gluten-free diet, steroids discontinued), bone density often improves measurably within 1–2 years. Complete reversal depends on how much bone was lost and how long the cause was present.
How is secondary osteoporosis different from primary osteoporosis on a DXA scan?
It isn’t — the DXA scan looks the same. That’s exactly the problem. DXA measures density but can’t tell you cause. The difference is in the clinical history and lab work, not the imaging. A Z-score (which compares you to age-matched peers rather than young adults) worse than -2.0 should raise strong suspicion for a secondary cause.
Should everyone on prednisone take bone protection medication?
Not necessarily everyone, but the threshold is lower than most doctors realize. The American College of Rheumatology recommends fracture risk assessment for any adult on prednisone ≥2.5 mg/day for ≥3 months. Those at moderate or high risk (based on FRAX score, age, dose, and prior fractures) should receive pharmacologic therapy — not just calcium and vitamin D.
What’s the most commonly missed cause of secondary osteoporosis?
Vitamin D deficiency with secondary hyperparathyroidism is arguably the most commonly overlooked contributor. Celiac disease is another — studies suggest up to 3–4% of patients with unexplained osteoporosis have undiagnosed celiac disease. A simple tTG-IgA blood test can identify it.
Can younger adults get secondary osteoporosis?
Absolutely. It’s the predominant form of osteoporosis in premenopausal women and men under 50. Eating disorders, type 1 diabetes, inflammatory bowel disease, and chronic steroid use are among the most common culprits in younger patients. Any young adult with a fragility fracture warrants a full workup.
